Cancer cells with strong cytoplasmic IGF1R immunostaining (c-IGF1R 2+) were observed in only 2 (1.4%) and cancer cells with a weak cytoplasmic immunostaining (c-IGF1R 1+) were seen in 13 (9.3%) cases. This evidence concerns the gene IGF1R and cancer.